| Product Name |
MF |
CAS |
Details |
| Lidocaine
Anestacon ; 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide |
C14H22N2O |
137-58-6 |
|
| Desloratadine N-Acetyl Impurity
Desloratadine N-Acetyl Impurity ; N-Acetyl Desloratadine |
C21H21ClN2O |
117796-52-8 |
|
| Paracetamol EP Impurity H
4-acetamidophenyl acetate |
C10H11NO3 |
2623-33-8 |
|
| Ethacrynic Acid impurity A
4-Butanoyl-2, 3-dichlorophenoxy acetic acid |
C12H12Cl2O4 |
1217-67-0 |
|
| Teriflunomide Impurity 18
2-cyano-N-(4-(trifluoromethyl)phenyl)acetamide |
C10H7F3N2O |
24522-30-3 |
|
| Leflunomide EP Impurity H
2-cyano-N-(4-(trifluoromethyl)phenyl)acetamide |
C10H7F3N2O |
24522-30-3 |
|
| Tirofiban
(S)-2-(butylsulfonamido)-3-(4-(4-(piperidin-4- yl)butoxy)phenyl)propanoic acid |
C22H36N2O5S |
144494-65-5 |
|
| Hydrochlorothiazide EP Impurity B
Hydrochlorothiazide USP Related Compound A |
C6H8ClN3O4S2 |
121-30-2 |
|
| Mesalazine EP Impurity R
2-hydroxy-3-nitrobenzoic acid (3-nitrosalicylic acid). ;
Mesalamine EP Impurity R |
C7H5NO5 |
85-38-1 |
|
| Mesalazine EP Impurity F
3-amino-2-hydroxybenzoic acid (3-aminosalicylic acid).; Mesalamine EP Impurity F |
C7H7NO3 |
570-23-0 |
|
| Thiamazole |
C4H6N2S |
60-56-0 |
|
| Memantine HCl
3,5-Dimethyltricyclo[3.3.1.13,7]decan-1-amine hydrochloride |
C12H22ClN |
41100-52-1 |
|
| Oxcarbazepine
10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide |
C15H12N2O2 |
28721-07-5 |
|
| Lacosamide EP Impurity D
(2R)-2-Amino-3-methoxy-N-(phenylmethyl)-propanamide. BP Impurity D |
C11H16N2O2 |
196601-69-1 |
|
| Amlodipine EP Impurity E
Amlodipine Diethyl Ester; 2-[(2-Aminoethoxy)methyl]-4-(2- chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylic Acid 3,5-Diethyl Ester |
C21H27ClN2O5 |
140171-65-9 |
|
| Lacosamide EP Impurity F
Desmethyl Lacosamide(Hydroxy Imp) |
C12H16N2O3 |
175481-38-6 |
|
| Quetiapine EP Impurity I HCl Salt
Quetiapine Desethoxy Impurity (USP) ; Quetiapine Alcohol Impurity |
C19H21N3OS |
329218-14-6 |
|
| Atenolol EP Impurity E
2,2'-[2-Hydroxypropan-1,3-diylbis(oxy-4,1- phenylene)diacetamide |
C19H22N2O5 |
141650-31-9 |
|
| Desloratadine N-Hydroxy Impurity |
C19H19ClN2O |
1193725-73-3 |
|
| Azilsartan medoxomil potassium |
C30H25KN4O8 |
863031-24-7
863031-21-4 |
|
| Azilsartan Impurity 4
Azilsartan Methyl Ester ; methyl 2-ethoxy-1-((2'-(5-oxo-4,5- dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H- benzo[d]imidazole-7-carboxylate |
C26H22N4O5 |
147403-52-9 |
|
| Olanzapine Amino Impurity
2-(2-Aminoanilino)-5-methylthiophene-3-carbonitrile |
C12H11N3S |
873895-41-1 |
|
| Haloperidol EP Impurity B
Haloperidol Related Compound B |
C21H23ClFNO2 |
1391052-53-1 |
|
| Donepezil hydroxy impurity
2,3-Dihydro-2-[hydroxy[1-(phenylmethyl)-4-piperidinyl]methyl]- 5,6-dimethoxy-1H-inden-1-one |
C24H29NO4 |
197010-20-1 |
|
| Leflunomide EP Impurity G
5-methyl-N-(p-tolyl)isoxazole-4-carboxamide |
C12H12N2O2 |
724429-16-7 |
|
| Tenegliptin impurity A
1-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazine |
C14H18N4 |
401566-79-8 |
|
| Azilsartan Impurity A
methyl 1-((2'-carbamoyl-[1,1'-biphenyl]-4-yl)methyl)
-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate |
C25H23N3O4 |
147404-76-0 |
|
| Montelukast (3RS)-Hydroxy Propanol |
C29H28ClNO2 |
959235-68-8 |
|
| Descyano Diclazuril Ketone (Impurity D)
2-[3,5-Dichloro-4-(4-chlorobenzoyl)phenyl]-1,2,4-triazine- 3,5(2H,4H)-dione |
C16H8Cl3N3O3 |
133648-81-4 |
|
| Quetiapine Fumarate
2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1- piperazinyl)ethoxy]ethanol hemifumarate |
C25H29N3O6S |
111974-72-2 |
|
| Dabigatran Impurity 9
Dabigatran Etexilate Methyl Ester Analog |
C33H39N7O5 |
211915-00-3 |
|
| Prasugrel Impurity 9
1-cyclopropyl-2-(2-fluorophenyl)-2-hydroxyethan-1-one |
C11H11FO2 |
1100905-45-0 |
|
| Bupivacaine EP Impurity E
6-(Butylamino)-N-(2,6-dimethylphenyl)hexanamide |
C18H30N2O |
1330172-81-0 |
|
| Cetirizine EP Impurity F
2-(2-(4-benzhydrylpiperazin-1-yl)ethoxy)acetic acid |
C21H26N2O3 |
83881-53-2 |
|
| (R)-Vildagliptin
(R)-1-(((1r,3S,5R,7S)-3-hydroxyadamantan-1- yl)glycyl)pyrrolidine-2-carbonitrile |
C17H25N3O2 |
1036959-27-9 |
|
| Vildagliptin Carboxamide Impurity
(2S)-1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]- 2-pyrrolidine carboxamide ; Vildagliptin Impurity 16 |
C17H27N3O3 |
565453-39-6 |
|
| Dabigatran Etexilate Isopropyl Ester Analog |
C35H43N7O5 |
1610758-19-4 |
|
| Flecainide acetate
N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2- trifluoroethoxy)benzamide acetate |
C19H24F6N2O5 |
54143-56-5 |
|
| Metolazone EP Impurity D
Metolazone USP RC E ; Didehydrometolazone |
C16H14ClN3O3S |
4015-23-0 |
|
| Brexpiprazole Impurity 4
7-(4-hydroxybutoxy)quinolin-2(1H)-one |
C13H15NO3 |
1886188-97-1 |
|
| Meloxicam EP Impurity D
Meloxicam USP RC D; N-[(2Z)-3-ethyl-5-methylthiazol-2(3H)- ylidene]-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3- carboxamide 1,1-dioxide |
C16H17N3O4S2 |
1331636-17-9 |
|
| Esomeprazole EP Impurity A
Omeprazole EP Impurity A ; 5-Methoxy-1H-benzimidazole-2- thiol |
C8H8N2OS |
37052-78-1 |
|
| Omeprazole EP Impurity A
Esomeprazole EP Impurity A ; 5-Methoxy-1H-benzimidazole-2- thiol |
C8H8N2OS |
37052-78-1 |
|
| Sitagliptin EP Impurity A
(S)-SitagliptinIsomer ;
(S)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3- a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine ; |
C16H15F6N5O |
823817-55-6 |
|
| N-Acetyl-O-methyl-D-serine
N-Acetyl-O-methyl-D-serine; (R)-2-(Acetylamino)-3- methoxypropionic Acid |
C6H11NO4 |
196601-67-9 |
|
| Tropicamide
(2RS)-N-Ethyl-3-hydroxy-2-phenyl-N-(pyridin-4- ylmethyl)propanamide |
C17H20N2O2 |
1508-75-4 |
|
| Fosfomycin Tromethamine
2-amino-2-(hydroxymethyl)propane-1,3-diol ((2R,3S)-3- methyloxiran-2-yl)
phosphonate |
C7H18NO7P |
78964-85-9 |
|
| Bumetanide
3-(butylamino)-4-phenoxy-5-sulfamoylbenzoic acid |
C17H20N2O5S |
28395-03-1 |
|
| Ethyl 3-methylisoxazole-4-carboxylate |
C7H9NO3 |
20328-15-8 |
|
| Paracetamol EP Impurity D
N-phenylacetamide |
C8H9NO |
103-84-4 |
|
| Nateglinide
(2R)-2-({[trans-4-(1-methylethyl)cyclohexyl]carbonyl}amino)-3- phenylpropanoic acid |
C19H27NO3 |
105816-04-4 |
|
| 4-Chlorophenol |
C6H5ClO |
106-48-9 |
|
| Chlortalidone EP impurity A
Chlorthalidone Chlorosulfobenzoyl Benzoic Acid Impurity |
C14H9ClO6S |
345930-32-7 |
|
| Amlodipine USP RC A
(3-Ethyl 5-methyl [2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)- 6-methyl-3,5-pyridinedicarboxylate fumarate) |
C24H27ClN2O9 |
2138811-33-1 |
|
| Rosuvastatin Calcium
(3R,5S,6E)-7-{4-(4-Fluorophenyl)-6-isopropyl-2- [methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5- dihydroxyhept-6-enoic acid calcium salt |
C22H30CaFN3O6S |
147098-20-2 |
|
| Brexpiprazole Di-N-Oxide
1-(Benzo[b]thiophen-4-yl)-4-(4-((2-oxo-l,2-dihydroquinolin-7- yl)oxy)butyl) piperazine 1,4-dioxide |
C25H27N3O4S |
2247155-42-4 |
|
| Hydroxynovaldiamine
2-[(4-aminopentyl)(ethyl)amino]ethan-1-ol |
C9H22N2O |
69559-11-1 |
|
| Mesalazine EP Impurity E
4-amino-2-hydroxybenzoic acid (4-aminosalicylic acid).;
Mesalamine EP Impurity E |
C7H7NO3 |
65-49-6 |
|
| Chlorobutoxy Dihydroquinolinone
7-(4-Chlorobutoxy)-3,4-dihydro-2(1H)-quinolinone; 7-(4- Chlorobutoxy)-3,4-dihydro-C2(1H)-quinoline |
C13H16ClNO2 |
120004-79-7 |
|
| Allopurinol EP Impurity A
Allopurinol USP RC A ; 5-amino-1H-pyrazole-4-carboxamide |
C8H14N8O6S |
27511-79-1 |
|
| Clonidine EP Impurity C
2,6-Dichloroaniline |
C6H5Cl2N |
608-31-1 |
|
| Ondansetron EP Impurity D
Related compound D, 9-methyl-3-methylene-1,2,3,9-tetrahydro 4H-carbazol-4-one |
C14H13NO |
99614-64-9 |
|
| Brexpiprazole Impurity 7
7-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)-1-(4-
(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butyl)quinolin-2(1H)- one |
C41H47N5O2S2 |
2137823-20-0 |
|
| Teriflunomide Impurity 4
1-ethoxy-4-(trifluoromethyl)benzene |
C9H9F3O |
2366-92-9 |
|
| Esketamine EP Impurity C
(2-chlorophenyl)(1-hydroxycyclopentyl)methanone |
C12H13ClO2 |
90717-17-2 |
|
| Diazepam EP Impurity B
2-Chloro-N-(4-chloro-2-benzoylphenyl)-N-methylacetamide |
C16H13Cl2NO2 |
6021-21-2 |
|
| Dabigatran Etexilate Dimer |
C59H64N14O7 |
2101852-25-7 |
|
| 1-Phenyl-3-oxabicyclo[3.1.0]hexan-2-one |
C11H10O2 |
63106-93-4 |
|
| Buspirone EP Impurity K
USP RC K ; 8-Azaspiro[4.5]decane-7,9-dione |
C9H13NO2 |
1075-89-4 |
|
| Lisinopril EP Impurity D
R,S,S-Diketopiperazine |
C21H29N3O4 |
219677-82-4 |
|
| Losartan EP Impurity K
Losartan USP RC C ; Losartan Aldehyde ; 2-Butyl-4-chloro-1-[p- (o-1H-tetrazol-5-ylphenyl)benzyl]imidazole-5-formaldehyde |
C22H21ClN6O |
114798-36-6 |
|
| Eprosartan
(E)-3-[2-Butyl-1-[(4-carboxyphenyl)methyl]-imidazol-5-yl]-2-(2- thienyl methyl)-2-propenoic acid |
C23H24N2O4S |
133040-01-4 |
|
| Venlafaxine HCl
1-[2-(Dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol hydrochloride |
C17H28ClNO2 |
99300-78-4 |
|
| Azilsartan Impurity C
2-ethoxy-1-((2'-(N'-hydroxycarbamimidoyl)
-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylic acid |
|
397836-49-5 |
|
| Zolpidem Tartrate EP Impurity B
2-[2-(3-bromo-4-methylphenyl)-6-methylimidazo[1,2-a]pyridin- 3-yl]-N,N-dimethylacetamide |
|
|
|
| Apixaban Impurity 5
3-morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)pyridin-2(1H)-
one |
|
|
|
| Glipizide
N-[2-
[4[[[(Cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-5- methylpyrazinecarboxamide |
|
9094-61-9 |
|
| Brimonidine EP Impurity B
5-bromoquinoxalin-6-amine |
|
|
|
| Doxazosin Mesylate
1-(4-Amino-6,7-dimethoxyquinazolin-2-yl)-4-[(2RS)-2,3-dihydro
-1,4-benzodioxin-2-ylcarbonyl]piperazine methanesulphonate |
|
77883-43-3
/74191-85-8 |
|
| Lacosamide EP Impurity H
USP Dimer (R, R isomer) |
|
|
|
| Anhydro tetracycline impurity
(4S,4aS,12aS)-4-(Dimethylamino)-1,4,4a,5,12,12a-Hexahydro- 3,10,11,12a-Tetrahydroxy-6-Methyl-1,12-Dioxotetracene-2-
Carboxamide |
|
|
|
| Closantel EP Impurity C
(2RS)-[2-Chloro-4-[(2-hydroxy-3,5-diiodobenzoyl)amino]-5-
methylphenyl](4-chlorophenyl)acetic acid |
|
|
|
| Ethacrynic Acid Impurity 4
[2,3-dichloro-4-(2-methylacryloyl)phenoxy]acetic acid |
|
|
|
| 1,3-bis(2-methoxyphenoxy)propan-2-ol
1,3-bis(2-methoxyphenoxy)propan-2-ol |
|
|
|
| 2-Butyl-3-(2-Methoxy benzoyl) benzofuran
(2-butyl-1-benzofuran-3-yl)(2-methoxyphenylmethanone |
|
|
|
| Tenteligliptin impurity 4
(2R)-4-Oxo-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic Acid 1,1-Dimethylethyl Ester |
|
|
|
| Ciprofloxacin EP Impurity C
Ciprofloxacin Ethylenediamine USP |
|
103222-12-4
/528851-31-2 |
|
| Sitagliptin Impurity 6
(R)-N-(4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo
[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2- yl)formamide |
|
|
|
| Brimonidine EP Impurity F
5-bromo-N-(1H-imidazol-2-yl)quinoxalin-6-amine |
|
|
|
| Tramadol EP Impurity A
Tramadol Related Compound A |
|
152538-36-
8/36282-47-0 |
|
| Vildagliptin Carboxylic Acid Impurity
(2S)-1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]- 2-pyrrolidine carboxylic acid |
|
|
|
| Ivabradine Impurity 14
3,3'-(propane-1,3-diyl)bis(7,8-dimethoxy-1,3,4,5-tetrahydro-2H- benzo[d]azepin-2-one) |
|
|
|
| Clopidogrel
S-(+)-Clopidogrel Hydrogen Sulfate |
|
113665-84-2/
120202-66-6 |
|
| Olmesartan Methyl Ether with Trityl |
|
|
|
| Tenteligliptin impurity C
(2S)-tert-butyl4-hydroxy-2-(thiazolidine-3-carbonyl)pyrrolidine- 1-carboxylate |
|
|
|
| Labetalol EP Impurity C
5-(2-(benzylamino)-1-hydroxyethyl)-2-hydroxybenzamide |
|
|
|
| Tenteligliptin impurity 3
3-[(2R,4S)-1-tert-Butoxycarbonyl-4-hydroxy-2-
pyrrolidinylcarbonyl]-1,3-thiazolidine |
|
|
|
| Chloro Intermedate
2-chloro-5-(1-oxoisoindolin-3-yl)benzene-1-sulfonyl chloride |
|
|
|
| Teneligliptin (2R,4R)-Isomer
{(2R4R)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazine-l- yl]pyrrolidine-2-yl}( 1.3-thiazolidine-3-yl) methanone hemipentahydrobromide hydrate |
|
1404559-17-6
(Free Base) |
|
| CHLOPIDOGREL HYDROGEN SULPHATE RACEMATE
( ±)-Methyl 2-(2-Chlorophenyl)-2-(6,7-dihydro-4H-thieno [3,2-c]pyridin-5-yl)acetate Hydrogen Sulfate |
|
135046-48-9
90055-48-4 |
|
